Evolution of biomarker research in autoimmunity conditions for health professionals and clinical practice
Arthur Silverstein1, Anton Dudaev2, Maria Studneva2,3, John Aitken4, Sofya Blokh5, Andrew David Miller6, Sofia Tanasova7, Noel Rose8, John Ryals9, Christoph Borchers10, Anders Nordstrom11, Marina Moiseyakh2, Arturo Solís Herrera12, Nikita Skomorohov2, Trevor Marshall13,14,15, Alan Wu16,17, R. Holland Cheng18, Ksenia Syzko2, Philip D. Cotter17,19, Marianna Podzyuban2
1Department of the History of Medicine, Johns Hopkins University, Baltimore, MD, United States
2MGUPP, Moscow, Russia
3EPMA (European Association for Predictive, Preventive and Personalized Medicine), Brussels, Belgium
4Otakaro Pathways, Christchurch, New Zealand
5Filatov's Moscow Clinical Pediatric Hospital, Moscow, Russia
6Mendel University and Veterinary Research Institute, Brno, Czech Republic
7A.I.Evdokimov Moscow State University of Medicine & Dentistry, Moscow, Russia
8Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States
9Mathematics Department at Central Georgia Technical College, Warner Robins, GA, United States
10Lady Davis Institute, Segal Cancer Proteomics Centre, McGill University, Montreal, QC, Canada
11Center for Proteomics, Faculty of Medicine, Department of Molecular Biology, Umea University, Umea, Sweden
12University of Florida, Gainesville, FL, United States
13University of Adelaide, Adelaide, SA, Australia
14Murdoch University, Murdoch, WA, Australia
15The Autoimmunity Research Foundation, Thousand Oaks, CA, United States
16San Francisco General Hospital, San Francisco, CA, United States
17UCSF, San Francisco, CA, United States
18College of Biological Sciences, UC Davis, Davis, CA, United States
19ResearchDx and PacificDx, Irvine, CA, United States
Thông tin
Thông tin xuất bản
Progress in Molecular Biology and Translational Science
Tập 190
219-276
Thông tin tác giả